Animal models of chronic thromboembolic pulmonary hypertensionOA
Chronic thromboembolic pulmonary hypertension(CTEPH)is a rare,yet life-threatening disorder characterized by persistent pulmonary vascular obstruction and elevated pulmonary artery pressure,with progressive remodeling and subsequent right heart failure.Despite substantial progress in elucidating the pathophysiology of CTEPH,the molecular mechanisms driving disease initiation and progression remain incompletely defined.Bridging these knowledge gaps and enabling the development of CTEPH-specific therapeutic strategies depend on experimental models that faithfully recapitulate the key pathological features observed in patients.A wide range of small-and large-animal models has therefore been established to mimic CTEPH development,each offering specific strengths and inherent limitations.Small animal models are relatively inexpensive,readily amenable to genetic manipulation,and well suited for high-throughput mechanistic investigations.However,their capacity to reproduce the complex pulmonary vascular architecture and hemodynamic characteristics of human disease is limited.By comparison,large-animal models more closely approximate human pulmonary anatomy and cardiovascular physiology,making them particularly valuable for detailed hemodynamic measurements and advanced imaging studies.Their broader application,however,is constrained by high financial costs,ethical considerations,and the need for specialized surgical and monitoring techniques.In this review,we provide an overview of currently available animal models of CTEPH,with emphasis on their methodological features,their ability to reproduce clinically relevant disease characteristics,and their potential utility in preclinical and translational research.
Yong-Jian Zhu;Lin-Chao Zhou;Xiao-Xue Zhang;Xiao-Yang Ren;Yi Yan;Shao-Fei Liu
Department of Cardiology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,ChinaDepartment of Cardio-Pulmonary Function,Henan Provincial People''s Hospital,Zhengzhou,ChinaDepartment of Cardiology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,ChinaDepartment of Cardiology,The First Affiliated Hospital of Zhengzhou University,Zhengzhou,ChinaHeart Center and Shanghai Institute of Pediatric Congenital Heart Disease,Pediatric Translational Medicine Institute,Shanghai Research Center for Pediatric Cardiovascular Diseases,Shanghai Children''s Medical Center,National Children''s Medical Center,Shanghai Jiao Tong University School of Medicine,Shanghai,ChinaDepartment of Cardiology,Changhai Hospital,Naval Medical University,Shanghai,China
医药卫生
animal modelschronic thromboembolism pulmonary hypertensionpulmonary hypertensionpulmonary vascular remodeling
《Animal Models and Experimental Medicine》 2026 (5)
P.886-897,12
Henan Province Science and Technology Research Project,Grant/Award Number:252102310259the Project of National Natural Science Foundation of China,Grant/Award Number:82570412Natural Science Foundation of Shanghai,Grant/Award Number:25ZR1401394the Pujiang Talent Program,Grant/Award Number:25PJD147。
评论